Tools & Techniques

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Model firsts</h1><h2 class="title-bottom webtitle">How quantitative systems pharmacology can pick the right dose for first-in-human trials</h2><div class="byline">Karen Tkach Tuzman, Associate Editor</div><div class="date"></div></div></div></div>

Applied BioMath LLC

Bial-Portela & Ca. S.A.

Certara Inc.

European Medicines Agency (EMA)

Merck & Co. Inc.

quantitative systems pharmacology

Fatty acid amide hydrolase (FAAH)

Model firsts

How quantitative systems pharmacology can help companies home in on the right dose for first-in-human trials.

How quantitative systems pharmacology can pick the right dose for first-in-human trials

<br/><br/><center><span style="font-size:1.75rem;font-weight:500;">Access this Article</span></center>

Paywall Not Entitled Title

Request a Trial

Purchase This Article

<center><span style="font-weight:300;">[Log in]{{login}}</span></center>

Paywall Sub log in

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

BioCentury-BayHelix East-West BioPharma Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home